Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1953
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 2
1954 6
1955 6
1956 1
1957 2
1958 2
1960 2
1961 1
1968 1
1986 2
1987 1
1989 2
1991 1
1992 2
1993 1
1994 1
1997 1
2002 1
2003 1
2004 1
2009 1
2010 2
2011 2
2012 1
2014 1
2015 2
2016 1
2021 1
2022 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant trastuzumab in HER2-positive breast cancer.
Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, Mackey J, Glaspy J, Chan A, Pawlicki M, Pinter T, Valero V, Liu MC, Sauter G, von Minckwitz G, Visco F, Bee V, Buyse M, Bendahmane B, Tabah-Fisch I, Lindsay MA, Riva A, Crown J; Breast Cancer International Research Group. Slamon D, et al. N Engl J Med. 2011 Oct 6;365(14):1273-83. doi: 10.1056/NEJMoa0910383. N Engl J Med. 2011. PMID: 21991949 Free PMC article. Clinical Trial.
Why use inbred lines?
BIGGERS JD, CLARINGBOLD PJ. BIGGERS JD, et al. Among authors: claringbold pj. Nature. 1954 Sep 25;174(4430):596-7. doi: 10.1038/174596a0. Nature. 1954. PMID: 13203582 No abstract available.
Samarium-153 EDTMP therapy of disseminated skeletal metastasis.
Turner JH, Martindale AA, Sorby P, Hetherington EL, Fleay RF, Hoffman RF, Claringbold PG. Turner JH, et al. Among authors: claringbold pg. Eur J Nucl Med. 1989;15(12):784-95. doi: 10.1007/BF00255498. Eur J Nucl Med. 1989. PMID: 2483138
47 results